“Glucagon Like Peptide (Glp – 1) Receptor: A Promising Therapeutic Target for Screening of Herbal Antidiabetic Compounds” (2018) Asian Journal of Pharmaceutics (AJP), 12(02). doi:10.22377/ajp.v12i02.2384.